- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Global Liver Institute Sends Request to CMS for OPO Metric Fix
The Global Liver Institute (GLI), along with other advocacy organizations, has sent a letter to CMS Administrator Seema Verma highlighting the United States' massive transplant waiting list, low organ recovery numbers, and need for change.
The Global Liver Institute (GLI), along with other advocacy organizations, has sent a letter to CMS Administrator Seema Verma highlighting the United States' massive transplant waiting list, low organ recovery numbers, and need for change. There are currently 115,000 people on the waiting list for organ transplants in the United States, and hundreds of thousands are likely to need transplants in the near future.
In the letter, GLI and the other advocacy organizations ask CMS to make an initial step in remedying the issue by substituting the metrics by which Organ Procurement Organizations are evaluated for a new verifiable metric that is not open to self-reported interpretation.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
